ABCELLERA BIOLOGICS

By integrating computation, engineering and biology, we aim to repeatedly develop differentiated antibody-based therapies from target to the clinic... We are a team of scientists, engineers, creatives, and business professionals who believe that advancing science enhances lives... AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera's engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners.

Also known as: AbCellera Biologics Inc

Primary location: Vancouver